CONTROLLED-RELEASE ORAL PREPARATION AND PREPARATION METHOD THEREFOR
A two-layer controlled-release oral preparation, which comprises a first ingredient as a quick-release layer and a second ingredient as a controlled-release layer, wherein the first ingredient comprises a xanthine derivative, and the second ingredient comprises a xanthine derivative and an enteric e...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
02.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A two-layer controlled-release oral preparation, which comprises a first ingredient as a quick-release layer and a second ingredient as a controlled-release layer, wherein the first ingredient comprises a xanthine derivative, and the second ingredient comprises a xanthine derivative and an enteric excipient. No more than 35% by weight of the xanthine derivative in the second ingredient is released within 90 min after in vitro elution, and 50% or more by weight of the xanthine derivative in the second ingredient is released within 3 h after in vitro elution.
Préparation orale à libération contrôlée en deux couches, qui comprend un premier ingrédient comme couche à libération rapide et un second ingrédient comme couche à libération contrôlée, le premier ingrédient comprenant un dérivé de xanthine, et le second ingrédient comprenant un dérivé de xanthine et un excipient entérique. Pas plus de 35 % en poids du dérivé de xanthine dans le second ingrédient est libéré en 90 min après l'élution in vitro, et 50 % ou p |
---|---|
Bibliography: | Application Number: WO2021CN109543 |